Comparison of Sino-Japanese innovative drug market access policy environment and enlightenment to China / 中国药科大学学报

This paper summarizes the current situation and existing problems of China's innovative drug market access policy from the basic aspects of innovative drug market access,such as intellectual property rights,drug pricing,medical insurance and bidding procurement.Based on the comprehensive analysis of Japan's innovative drug market access policy,through the comprehensive comparison of the two countries innovative drug market access policy differences,the paper put forward the practical measures to encourage the listing of innovative drugs in China,from the intellectual property rights,drug pricing,medical security and tender procurement in four areas.

Policy, experience and implications of outpatient security in typical developed countries / 中国卫生政策研究

This paper reviews outpatient security policy of typical developed countries .It provides reference for outpatient security system in China .Analysts believe that the experience for Chinese reference should be acquired in the following ways:The pooling of outpatient service is an inevitable trend in the development of health insurance , which is in principle an integral part of payment and financing system; the implementation of outpatient community first diagnosis system should be adapted to the local conditions; the community first diagnosis system is a necessary condition for capitation , so it is closely related to compensation methods and the elaborate degree of outpatient treat -ment catalog;Outpatient services should be supervised and payment policies should be developed respectively .There are two supervision models about outpatient service:external supervision and self supervision , but the key is to focus on the management of outpatient doctors .External regulation should be consistent with the current regulatory approach of the situation and patients have to bear some responsibilities for outpatient treatment expenses in some proportions , but the payment cap line should not to be low .The implementation of certain preferential policies for vulnerable groups can be considered under the harmonized system to partially reduce their medical expenses .

Políticas comparadas de saúde suplementar no contexto de sistemas públicos de saúde: União Européia e Brasil / Compared supplementary healthcare policies in the context of public health systems: European Union and Brazil

O artigo a seguir propõe-se analisar a política de saúde suplementar nos anos recentes no Brasil e em países europeus. A abordagem proposta é a análise comparativa de políticas de planos e seguros privados no contexto de sistemas públicos de saúde, União Européia e Brasil. Foram comparadas as políticas dos países acima mencionados, o que possibilitou estabelecer parâmetros e categorias de análise capazes de evidenciar as semelhanças e diferenças que tais experiências comportam. Aprofundou-se a discussão destas variáveis/categorias de análise, para o caso de Brasil, utilizando resultados de pesquisa recentes sobre o setor privado da saúde no contexto do SUS. Indagaram-se especialmente: os convênios e contratos do setor público com o privado, as atribuições dos planos privados no sistema de saúde, a produção, capacidade instalada e financiamento dos setores público e privado e, por último, a regulação e ressarcimento dos planos privados ao SUS. Nas conclusões, retomamos a discussão da perspectiva teórico-conceitual na análise de políticas comparadas de sistemas de saúde e os aportes que nosso estudo providenciou.

This paper analyzes the supplementary healthcare policies adopted in recent years in Brazil and in European countries. The proposed approach is a comparative analysis of the private health plan and insurance policies in the context of the European Union and Brazilian public health systems. This comparison allowed establishing parameters and categories capable of showing the differences and similarities between these experiences. These variables served as a basis for analyzing the Brazilian case using recent results of studies on private health insurance in the context of the Unified Health System (SUS), the Brazilian Public Health System. The main topics investigated were: the contracts and agreements between the public and the private sector, the attributions of the private health care services in the public system, the production, available capacity and financing of the public and private health systems and finally, the regulations regarding reimbursement of the SUS in those cases, where users covered by the private sector made use of the public services. We conclude retaking the discussion of the theoretical and conceptual perspective in the comparative analysis of health system policies based on the insights originated by this work.